NASDAQ:RTTR - Ritter Pharmaceuticals News Headlines

Sign in or create an account to add this stock to your watchlist.
$0.79 +0.02 (+2.60 %)
(As of 12/16/2018 11:59 AM ET)
Previous Close$0.79
Today's Range$0.76 - $0.80
52-Week Range$0.71 - $4.00
Volume42,267 shs
Average Volume42,426 shs
Market Capitalization$4.53 million
P/E RatioN/A
Dividend YieldN/A
Beta1.15

Headlines

Ritter Pharmaceuticals (NASDAQ RTTR) News Headlines

Source:
DateHeadline
Ritter Pharma (RTTR) Reports Over 50% Enrollment in Pivotal Phase 3 Clinical Trial of RP-G28 in Patients with Lactose Intolerance - StreetInsider.comRitter Pharma (RTTR) Reports Over 50% Enrollment in Pivotal Phase 3 Clinical Trial of RP-G28 in Patients with Lactose Intolerance - StreetInsider.com
www.streetinsider.com - December 6 at 4:10 PM
Ritter Pharmaceuticals Reaches Halfway Mark for Enrollment in Pivotal Phase 3 Clinical Trial of RP-G28 in Patients with Lactose Intolerance - GlobeNewswireRitter Pharmaceuticals Reaches Halfway Mark for Enrollment in Pivotal Phase 3 Clinical Trial of RP-G28 in Patients with Lactose Intolerance - GlobeNewswire
globenewswire.com - December 6 at 4:10 PM
Ritter Pharmaceuticals Reaches Halfway Mark for Enrollment in Pivotal Phase 3 Clinical Trial of RP-G28 in Patients with Lactose IntoleranceRitter Pharmaceuticals Reaches Halfway Mark for Enrollment in Pivotal Phase 3 Clinical Trial of RP-G28 in Patients with Lactose Intolerance
finance.yahoo.com - December 4 at 10:03 AM
Zacks: Analysts Expect Ritter Pharmaceuticals Inc (RTTR) Will Announce Earnings of -$0.93 Per ShareZacks: Analysts Expect Ritter Pharmaceuticals Inc (RTTR) Will Announce Earnings of -$0.93 Per Share
www.americanbankingnews.com - November 30 at 3:18 AM
Consolidated Research: 2018 Summary Expectations for E*TRADE Financial, Ballantyne Strong, Lincoln Educational ...Consolidated Research: 2018 Summary Expectations for E*TRADE Financial, Ballantyne Strong, Lincoln Educational ...
globenewswire.com - November 25 at 9:45 AM
Ritter Pharmaceuticals Reports Financial Results for the Three and Nine Months Ended September 30, 2018 and ...Ritter Pharmaceuticals Reports Financial Results for the Three and Nine Months Ended September 30, 2018 and ...
globenewswire.com - November 9 at 10:16 AM
Ritter Pharmaceuticals Reports Financial Results for the Three and Nine Months Ended September 30, 2018 and Recent ProgressRitter Pharmaceuticals Reports Financial Results for the Three and Nine Months Ended September 30, 2018 and Recent Progress
finance.yahoo.com - November 9 at 10:16 AM
Ritter Pharmaceuticals Announces Closing of $6.0 Million At-Market Private Placement of Series B Convertible ...Ritter Pharmaceuticals Announces Closing of $6.0 Million At-Market Private Placement of Series B Convertible ...
www.nasdaq.com - November 8 at 9:58 AM
Form 8-K RITTER PHARMACEUTICALS For: Nov 06Form 8-K RITTER PHARMACEUTICALS For: Nov 06
www.streetinsider.com - November 8 at 9:58 AM
Ritter Pharmaceuticals Announces Closing of $6.0 Million At-Market Private Placement of Series B Convertible Preferred Stock and WarrantsRitter Pharmaceuticals Announces Closing of $6.0 Million At-Market Private Placement of Series B Convertible Preferred Stock and Warrants
finance.yahoo.com - November 6 at 9:48 AM
Ritter Pharmaceuticals Announces Agreement for $6.0 Million At-Market Private Placement of Series B Convertible ...Ritter Pharmaceuticals Announces Agreement for $6.0 Million At-Market Private Placement of Series B Convertible ...
globenewswire.com - October 31 at 10:09 AM
Ritter Pharmaceuticals Announces Agreement for $6.0 Million At-Market Private Placement of Series B Convertible Preferred Stock and WarrantsRitter Pharmaceuticals Announces Agreement for $6.0 Million At-Market Private Placement of Series B Convertible Preferred Stock and Warrants
finance.yahoo.com - October 31 at 10:09 AM
Ritter Pharma (RTTR) Presents Additional Phase 2b Data Showing Adaptation of the Gut Microbiome in Lactose Intolerance Patients at ACGRitter Pharma (RTTR) Presents Additional Phase 2b Data Showing Adaptation of the Gut Microbiome in Lactose Intolerance Patients at ACG
www.streetinsider.com - October 10 at 9:46 AM
Ritter Pharma up 11% premarket on RP-G28 dataRitter Pharma up 11% premarket on RP-G28 data
seekingalpha.com - October 9 at 3:54 PM
Ritter Pharmaceuticals Presents Additional Phase 2b Data Showing Adaptation of the Gut Microbiome in Lactose Intolerance Patients at American College of Gastroenterology Scientific MeetingRitter Pharmaceuticals Presents Additional Phase 2b Data Showing Adaptation of the Gut Microbiome in Lactose Intolerance Patients at American College of Gastroenterology Scientific Meeting
finance.yahoo.com - October 9 at 9:30 AM
Global Microbiome Therapeutics and Diagnostics Pipeline Analysis and Market Outlook to 2027 - Several Key Leading ...Global Microbiome Therapeutics and Diagnostics Pipeline Analysis and Market Outlook to 2027 - Several Key Leading ...
www.prnewswire.com - October 4 at 3:57 PM
Ritter Pharma down 12% after corporate presentationRitter Pharma down 12% after corporate presentation
seekingalpha.com - September 6 at 3:57 PM
Ritter Pharmaceuticals to Present at 20th Annual HC Wainwright Global Investment Conference on September 5, 2018Ritter Pharmaceuticals to Present at 20th Annual HC Wainwright Global Investment Conference on September 5, 2018
finance.yahoo.com - August 28 at 3:57 PM
Ritter Pharmaceuticals Reports Financial Results for the Three and Six Months Ended June 30, 2018 and Recent ProgressRitter Pharmaceuticals Reports Financial Results for the Three and Six Months Ended June 30, 2018 and Recent Progress
finance.yahoo.com - August 15 at 9:48 AM
Ritter Pharma (RTTR) Commences First Pivotal Phase 3 Trial for RP-G28 for the Treatment of Lactose IntoleranceRitter Pharma (RTTR) Commences First Pivotal Phase 3 Trial for RP-G28 for the Treatment of Lactose Intolerance
www.streetinsider.com - June 27 at 11:47 AM
Ritter Pharmaceuticals initiates first pivotal Phase 3 trial for RP-G28Ritter Pharmaceuticals initiates first pivotal Phase 3 trial for RP-G28
seekingalpha.com - June 27 at 11:47 AM
Ritter Pharmaceuticals names Andrew J. Ritter as CEORitter Pharmaceuticals names Andrew J. Ritter as CEO
seekingalpha.com - June 27 at 11:47 AM
Ritter Pharmaceuticals Initiates First Pivotal Phase 3 Trial for RP-G28 for the Treatment of Lactose IntoleranceRitter Pharmaceuticals Initiates First Pivotal Phase 3 Trial for RP-G28 for the Treatment of Lactose Intolerance
finance.yahoo.com - June 27 at 11:47 AM
Ritter Pharmaceuticals Announces Appointment of Andrew J. Ritter as Chief Executive OfficerRitter Pharmaceuticals Announces Appointment of Andrew J. Ritter as Chief Executive Officer
finance.yahoo.com - June 27 at 11:47 AM
Ritter Pharma (RTTR) Announces Key Phase 2b Clinical Trial Data of RP-G28 for Lactose IntoleranceRitter Pharma (RTTR) Announces Key Phase 2b Clinical Trial Data of RP-G28 for Lactose Intolerance
www.streetinsider.com - June 6 at 4:19 PM
Ritter Pharmaceuticals Highlights Key Phase 2b Clinical Trial Data of RP-G28 for Lactose Intolerance at Digestive ...Ritter Pharmaceuticals Highlights Key Phase 2b Clinical Trial Data of RP-G28 for Lactose Intolerance at Digestive ...
globenewswire.com - June 6 at 4:19 PM
Ritter Pharmaceuticals Is Likely A ZeroRitter Pharmaceuticals Is Likely A Zero
seekingalpha.com - June 6 at 4:19 PM
Ritter Pharmaceuticals highlights 2b clinical trial data of RP-G28 for lactose intolerance at Digestive Disease Week 2018Ritter Pharmaceuticals highlights 2b clinical trial data of RP-G28 for lactose intolerance at Digestive Disease Week 2018
seekingalpha.com - June 5 at 4:13 PM
Ritter Pharmaceuticals Highlights Key Phase 2b Clinical Trial Data of RP-G28 for Lactose Intolerance at Digestive Disease Week 2018Ritter Pharmaceuticals Highlights Key Phase 2b Clinical Trial Data of RP-G28 for Lactose Intolerance at Digestive Disease Week 2018
finance.yahoo.com - June 5 at 9:33 AM
Ritter Pharmaceuticals appoints John W. Beck as CFORitter Pharmaceuticals appoints John W. Beck as CFO
seekingalpha.com - May 29 at 9:34 AM
Ritter Pharmaceuticals Announces Appointment of John W. Beck as Chief Financial OfficerRitter Pharmaceuticals Announces Appointment of John W. Beck as Chief Financial Officer
finance.yahoo.com - May 29 at 9:34 AM
Ritter Pharmaceuticals to Present Two Posters at Digestive Disease Week 2018 Highlighting Treatment Data of RP ...Ritter Pharmaceuticals to Present Two Posters at Digestive Disease Week 2018 Highlighting Treatment Data of RP ...
globenewswire.com - May 24 at 4:10 PM
Ritter Pharmaceuticals to Present Two Posters at Digestive Disease Week 2018 Highlighting Treatment Data of RP-G28 for Lactose IntoleranceRitter Pharmaceuticals to Present Two Posters at Digestive Disease Week 2018 Highlighting Treatment Data of RP-G28 for Lactose Intolerance
finance.yahoo.com - May 22 at 9:46 AM
Ritter Pharmaceuticals Reports First Quarter 2018 Financial Results and Provides Business UpdatesRitter Pharmaceuticals Reports First Quarter 2018 Financial Results and Provides Business Updates
finance.yahoo.com - May 16 at 10:37 AM
Ritter Pharma (RTTR) Reports 1-for-10 Reverse Share Split - StreetInsider.comRitter Pharma (RTTR) Reports 1-for-10 Reverse Share Split - StreetInsider.com
www.streetinsider.com - March 22 at 4:13 PM
Ritter Pharmaceuticals Announces 1-for-10 Reverse Stock Split - GlobeNewswire (press release)Ritter Pharmaceuticals Announces 1-for-10 Reverse Stock Split - GlobeNewswire (press release)
www.globenewswire.com - March 22 at 4:13 PM
Ritter Pharmaceuticals Announces 1-for-10 Reverse Stock SplitRitter Pharmaceuticals Announces 1-for-10 Reverse Stock Split
finance.yahoo.com - March 22 at 4:13 PM
Ritter Pharmaceuticals Reports Fourth Quarter and Full Year 2017 ... - GlobeNewswire (press release)Ritter Pharmaceuticals Reports Fourth Quarter and Full Year 2017 ... - GlobeNewswire (press release)
globenewswire.com - March 19 at 4:11 PM
Ritter Pharmaceuticals Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Business UpdateRitter Pharmaceuticals Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Business Update
finance.yahoo.com - March 19 at 10:38 AM
Ritter Pharma (RTTR) Announces Microbiome Data from Phase 2b Study of RP-G28 Promotes Beneficial Adaptation of Gut MicrobiomeRitter Pharma (RTTR) Announces Microbiome Data from Phase 2b Study of RP-G28 Promotes Beneficial Adaptation of Gut Microbiome
www.streetinsider.com - March 14 at 4:07 PM
Ritter Pharmaceuticals Reports Microbiome Data from Phase 2b ... - GlobeNewswire (press release)Ritter Pharmaceuticals Reports Microbiome Data from Phase 2b ... - GlobeNewswire (press release)
globenewswire.com - March 12 at 4:01 PM
Ritter Pharmaceuticals Reports Microbiome Data from Phase 2b Study of RP-G28 Promotes Beneficial Adaptation of the Gut MicrobiomeRitter Pharmaceuticals Reports Microbiome Data from Phase 2b Study of RP-G28 Promotes Beneficial Adaptation of the Gut Microbiome
finance.yahoo.com - March 12 at 4:01 PM
Ritter Pharma (RTTR) Approves 1-for-10 Reverse Stock SplitRitter Pharma (RTTR) Approves 1-for-10 Reverse Stock Split
www.streetinsider.com - March 2 at 10:14 AM
Ritter Pharmaceuticals, Inc.’s Board Approves 1-for-10 Reverse Stock SplitRitter Pharmaceuticals, Inc.’s Board Approves 1-for-10 Reverse Stock Split
finance.yahoo.com - March 2 at 10:14 AM
Ritter Pharmaceuticals Appoints Distinguished Gastroenterologist, William Chey, MD, to Medical Advisory Board - GlobeNewswire (press release)Ritter Pharmaceuticals Appoints Distinguished Gastroenterologist, William Chey, MD, to Medical Advisory Board - GlobeNewswire (press release)
globenewswire.com - February 22 at 4:06 PM
Ritter Pharmaceuticals Appoints Diane J. Plotkin as Vice President ... - GlobeNewswire (press release)Ritter Pharmaceuticals Appoints Diane J. Plotkin as Vice President ... - GlobeNewswire (press release)
globenewswire.com - January 29 at 3:20 PM
Ritter Pharmaceuticals Appoints Diane J. Plotkin as Vice President of Clinical Development, Ahead of the Launch of its Phase 3 Clinical TrialRitter Pharmaceuticals Appoints Diane J. Plotkin as Vice President of Clinical Development, Ahead of the Launch of its Phase 3 Clinical Trial
finance.yahoo.com - January 29 at 3:20 PM
Ritter Pharmaceuticals Inc (NASDAQ:RTTR): Earnings To Drop Next Year, Is It A Long-Term Trend?Ritter Pharmaceuticals Inc (NASDAQ:RTTR): Earnings To Drop Next Year, Is It A Long-Term Trend?
finance.yahoo.com - January 2 at 9:09 PM
Try Rising P/E Investing With 5 Top-Ranked Stocks - NasdaqTry Rising P/E Investing With 5 Top-Ranked Stocks - Nasdaq
www.nasdaq.com - December 19 at 3:45 PM
Who Are Ritter Pharmaceuticals Inc’s (RTTR) Major Shareholders?Who Are Ritter Pharmaceuticals Inc’s (RTTR) Major Shareholders?
finance.yahoo.com - December 9 at 11:12 AM
This page was last updated on 12/16/2018 by MarketBeat.com Staff

Featured Article: What is an SEC Filing?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel